Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 4;15(3):368.
doi: 10.3390/biom15030368.

Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence

Affiliations

Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence

Sepehr Pourebrahim et al. Biomolecules. .

Abstract

Cannabis abuse has been linked to acute psychotic symptoms as well as to the development of schizophrenia. Although the association has been well described, causation has not yet been investigated. Therefore, we investigated whether cannabis or cannabinoid use is causal for the development of schizophrenia, conducting a systematic literature review according to the PRISM guidelines. Epidemiological studies and randomized clinical trials investigating the links between cannabis and psychosis-like events (PLE) and schizophrenia were identified (according to PRISM guidelines), and relevant studies were included in a Forest plot analysis. Confounder analysis was performed using a funnel plot, and the Hill causality criteria were used to estimate causation. A total of 18 studies fulfilled the search criteria; 10 studies were included in a forest plot. All studies reported an increased risk for PLE or schizophrenia, and nine of the ten studies, a significant increase; the overall OR was calculated to be 2.88 (CI 2.24 to 3.70), with a twofold-higher risk calculated for cannabis use during adolescence. Confounder effects were indicated by a funnel plot. The Hill criteria indicated a high likelihood for the contribution of cannabis to schizophrenia development. Cannabinoids likely contribute to chronic psychotic events and schizophrenia, especially if taken during adolescence. This effect likely increases with a high cannabis THC concentration and increased frequency of cannabis use, and is stronger in males than in females. This points to the possibility of a selective cannabis toxicity on synaptic plasticity in adolescence, as compared to adult cannabis use. Cannabis use should be regulated and discouraged, and prevention efforts should be strengthened, especially with reference to adolescence.

Keywords: cannabinoids; causality assessment; dihydrocannabidiol; psychosis; tetrahydrocannabinol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISM flow chart for study inclusion and exclusion factors.
Figure 2
Figure 2
Possibility of bias in the publications identified in the literature search [25,26,27,28,29,30,31,32,33,34,36,37,38,39,40,41,42,43].
Figure 3
Figure 3
Forest plot for the association of psychosis/schizophrenia and cannabis use [25,26,27,28,29,30,31,32,33,38].

References

    1. UNDOC (United Nations Office on Drug and Crime) Online World Drug Report 2024—Drug Market Patterns and Trends. [(accessed on 11 October 2024)]. Available online: https://www.unodc.org/unodc/en/data-and-analysis/wdr2024-drug-market-tre....
    1. Casadio P., Fernandes C., Murray R.M., Di Forti M. Cannabis use in young people: The risk for schizophrenia. Neurosci. Biobehav. Rev. 2011;35:1779–1787. doi: 10.1016/j.neubiorev.2011.04.007. - DOI - PubMed
    1. Hong G.W., Sideris A., Waldman S., Stauffer J.D.O., Wu C.L. Legal and Regulatory Aspects of Medical Cannabis in the United States. Anesth. Analg. 2024;138:31–41. doi: 10.1213/ANE.0000000000006301. - DOI - PubMed
    1. Kruger D.J., Gerlach J., Kruger J.S., Mokbel M.A., Clauw D.J., Boehnke K.F. Physicians’ Attitudes and Practices Regarding Cannabis and Recommending Medical Cannabis Use. Cannabis Cannabinoid Res. 2024;9:e1048–e1055. doi: 10.1089/can.2022.0324. - DOI - PMC - PubMed
    1. Troyer J., Tanco K. Review of the Use of Medicinal Cannabis Products in Palliative Care. Cancers. 2024;16:1412. doi: 10.3390/cancers16071412. - DOI - PMC - PubMed

Publication types

LinkOut - more resources